-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-30
Saito and colleagues developed a streamlined direct three-dimensional culture strategy for generating human induced pluripotent stem cell-derived intestinal organoids with long-term expansion, differentiation capacity, and cryopreservation potential. The resulting intestinal epithelial cells contained mature enterocyte-like populations with cytochrome P450 and transporter activities, supporting a more human-relevant platform for oral drug absorption and metabolism studies.
-
DiscoveryProbe Immunology/Inflammation Compound Library
2026-09-29
Build higher-resolution immune screens by pairing 295 curated small molecules with multiplex PBMC flow cytometry. This workflow connects phenotypic hits to inflammation target validation while reducing false positives caused by single-marker assays, donor effects, or compound-handling artifacts.
-
Perifosine (KRX-0401): From Akt Biology to Translation
2026-09-29
Perifosine (KRX-0401) is more than a cytotoxic research compound: it is a mechanistic probe for Akt-dependent survival, apoptosis, radiosensitization, and context-specific PI3K/Akt/mTOR biology. This article outlines how translational researchers can use it to connect cancer models with pathway-focused neuroprotection research while preserving experimental rigor.
-
Lysosomal β-Galactosidase Staining Kit in HNSCC
2026-09-28
Use the Lysosomal β-Galactosidase Staining Kit as a visual readout of lysosomal enzyme activity when investigating senescence-associated phenotypes in cisplatin-treated HNSCC models. Its value is as a carefully interpreted control stain—not a stand-alone test for senescence or proof of drug resistance.
-
Recombinant Human Growth Hormone: Reading Cell Responses
2026-09-27
Recombinant Human Growth Hormone can do more than trigger a growth readout: carefully designed experiments can distinguish ligand activity from downstream pathway competence. Explore how evidence on the IGFBP2–THBS1–IGF-1 axis can guide assay interpretation without overextending findings from cell models.
-
MK-8745: An Aurora A Inhibitor Workflow
2026-09-26
Use MK-8745 to connect Aurora A inhibition with mitotic arrest and apoptosis readouts, while testing how response varies with p53 status. A retinoblastoma study strengthens the rationale for investigating AURKA in high-risk tumors—but does not establish MK-8745 as a validated treatment for retinoblastoma.
-
Nocodazole at the Metabolism–Microtubule Interface
2026-09-26
New findings on α-tubulin lactylation connect cellular metabolism with microtubule behavior. This article considers how Nocodazole can help translational researchers probe that biology, design interpretable experiments, and distinguish a useful cytoskeletal perturbation from evidence of a specific mechanism.
-
Leucovorin Calcium for Tumor Assembloid Assay Design
2026-09-25
Leucovorin Calcium can serve as a mechanistic rescue probe in methotrexate studies, but its meaning changes when tumor organoids are combined with patient-matched stroma. This article explains how to design and interpret folate-rescue assays without mistaking a mixed-cell viability signal for tumor-cell resistance.
-
ER-Targeted Peptide Self-Assembly in Cancer Cells
2026-09-25
The study couples alkaline phosphatase-triggered peptide self-assembly with an endoplasmic reticulum-targeting group to concentrate assemblies in cancer-cell ER. The approach increased cell-fate effects relative to non-targeted intracellular assembly, with a reported greater-than-twofold reduction in IC50, while the findings remain specific to the tested EISA design and do not establish a caspase-4 or pyroptosis mechanism.
-
Mubritinib (TAK 165): Applied Assay Guide
2026-09-24
Use Mubritinib to probe complex I dependence in chemotherapy-resistant AML and KSHV-positive PEL—not as a stand-in for clinically relevant HER2 inhibition. This guide outlines model selection, practical dosing workflows, assay controls, and troubleshooting for interpreting metabolic and cell-death readouts.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Guide
2026-09-24
See how this Cy3 conjugated secondary antibody can make human IgG visible in microscopy, flow cytometry, and fluorescence ELISA workflows. The guide also explains a critical assay boundary: it can detect human antibodies in orthopoxvirus research, but it is not a match for the mouse monoclonal antibodies characterized in the featured study.
-
Procainamide Reduces Cisplatin Hepatotoxicity in Rats
2026-09-23
The reference study shows that procainamide hydrochloride reduced biochemical and histological evidence of cisplatin-induced liver injury in rats while changing hepatic platinum disposition. Its main innovation is the integration of hepatotoxicity endpoints with platinum–DNA adducts, DNA cross-links, subcellular platinum distribution, and a chemical interaction model.
-
FLT3–TAZ Signaling in Drug-Resistant BP-CML
2026-09-23
Shin et al. identify FLT3 as a prognostic marker and therapeutic vulnerability in blast phase chronic myeloid leukemia (BP-CML), even though FLT3 is more commonly associated with acute myeloid leukemia. Their data connect FLT3 to a JAK–STAT3–TAZ–TEAD–CD36 axis that promotes resistance to BCR::ABL1 tyrosine kinase inhibitors and suggest that FLT3-directed or ponatinib-based strategies can restore antileukemic activity.
-
CHIR-99021: GSK-3 Inhibition in Stem Cell Research
2026-09-22
CHIR-99021, also called CT99021, is a selective glycogen synthase kinase-3 inhibitor used to modulate Wnt/β-catenin signaling in stem-cell and differentiation workflows. Its reported biochemical potency supports experimental use, but cellular concentration, exposure time, lineage, and vehicle conditions require independent optimization.
-
Caspase-4 Colorimetric Assay Kit Guide
2026-09-21
The Caspase-4 Colorimetric Assay Kit measures LEVD-dependent caspase-4 activity through LEVD-pNA cleavage and p-nitroaniline detection. This colorimetric caspase assay supports quantitative inflammation and pyroptosis experiments, but its enzymatic signal should not be treated as standalone proof of pyroptotic cell death.